Longitudinal studies of viral sequence, viral phenotype, immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 3589-3598

  Hutto, Cecelia ^a   Zhou, Y I ^a   Jun, H E ^a   Geffin, Rebeca ^a   Hill, Martin ^a   Scott, Walter ^a   Wood, Charles ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OPPORTUNISTIC INFECTION; PERINATAL INFECTION; PHENOTYPE; PRIORITY JOURNAL; TWINS; VIRUS CULTURE; VIRUS MORPHOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AMINO ACID SEQUENCE; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; BASE SEQUENCE; CHILD, PRESCHOOL; CLONING, MOLECULAR; DISEASE TRANSMISSION, VERTICAL; DISEASES IN TWINS; FEMALE; HIV-1; HUMANS; INFANT; LONGITUDINAL STUDIES; MOLECULAR SEQUENCE DATA; PHENOTYPE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0029979022     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Siedman, J. A. Smith, and K. Struhl (ed.). 1910. Current protocols in molecular biology. Greene Publishing Associates and Wiley Interscience, New York.
2. Blanche, S., M.-J. Mayaux, C. Rouzioux, J.-P. Teslas, G. Firtion, F. Monpoux, N. Ciraru-Visneron, F. Meier, J. Tricoire, O. Courpotin, E. Vilmer, C. Griscelli, J.-F. Delfraissy, and The French Pediatric HIV Infection Study Group. 1994. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N. Engl. J. Med. 330:308-312.
3. Blanche, S., M. Tardieu, A. Duliege, C. Rouzioux, F. Le Deist, K. Fukunaga, M. Caniglia, C. Jacomet, A. Messiah, and C. Griscelli. 1990. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Am. J. Dis. Child. 144:1210-1215.
4. Boyd, M. T., G. R. Simpson, A. J. Cann, M. A. Johnson, and R. A. Weiss. 1993. A single amino acid substitution in the V3 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J. Virol. 67:3649-3652.
5. Broliden, K., E. Sievers, P. A. Tovo, V. Moschese, G. Scarlatti, P. A. Broliden, C. Fundaro, and P. Rossi. 1993. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children. Clin. Exp. Immunol. 93:56-64.
6. Cheng-Mayer, C., T. Shioda, and J. A. Levy. 1991. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J. Virol. 65:6931-6941.
7. Cheng-Mayer, C., C. Weiss, D. Seto, and J. A. Levy. 1989. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc. Natl. Acad. Sci. USA 86:8575-8579.
8. Cheseboro, B., K. Wehrly, J. Nishio, and S. Ferryman. 1992. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell tropic isolates: definition of initial amino acids involved in cell tropism. I. Virol. 66:6547-6554.
9. Connor, R. I., and D. D. Ho. 1994. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:4400-4408.
10. Delwart, E. L., H. W. Sheppard, B. D. Walker, J. Goudsmit, and J. D. Mullins. 1994. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J. Virol. 68:6672-6683.
11. De Rossi, A., C. Giaquinto, L. Omette, F. Mammano, C. Zanotto, D. Dunn, and L. Chieco-Bianchi. 1993. Replication and tropism of human immuno-deficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection. J. Pediatr. 123:929-936.
12. Dickover, R. E., M. Dillon, S. G. Gillette, A. Deveikis, M. Keller, S. Plaeger-Marshall, I. Chen, A. Diagne, E. R. Stiehm, and Y. Bryson. 1994. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J. Infect. Dis. 170:1279-1284.
13. Felsenstein, J. 1993. PHYLIP, version 3.5c. (Copyright Felsenstein and the University of Washington.)
14. Fouchier, R. A., M. Groenink, N. A. Kootstra, M. Tersmette, H. G. Huisman, F. Miedema, and H. Schuitemaker. 1992. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66:3183-3187.
15. Freed, E. O., and M. A. Martin. 1994. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68:2503-2512.
16. Grimaila, R. J., B. A. Fuller, P. D. Rennert, M. B. Nelson, M. L. Hammarskjold, B. Potts, M. Murray, S. Putney, and G. Gary. 1992. Mutations in the principal neutralizing determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization. J. Virol. 66:1875-1883.
17. Henrard, D., M. Fauvel, J. Samson, G. Delage, M. Boucher, C. Hankjns, J. Stephens, and N. Lapointe. 1993. Ontogeny of the humoral immune response to human immunodeficiency virus type 1 in infants. J. Infect. Dis. 168:288-291.
18. Hollinger, F. B., J. W. Bremer, L. E. Myers, J. M. Gold, L. McQuay, and the NIH/NIAID/DAIDS/ACTG Virology Laboratories. 1992. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J. Clin. Microbiol. 30:1787-1794.
19. Holmes, E. C., L. Q. Zhang, P. Simnlonds, C. A. Ludlam, and A. J. Brown. 1992. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type I within a single infected patient. Proc. Natl. Acad. Sci. USA 89:4835-4839.
20. Italian Registrar for HIV infection in Children. 1994. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 343:191-195.
21. Japour, A. J., S. A. Fiscus, J. M. Arduino, D. L. Mayers, P. S. Reichelderfer, and D. R. Kuritzkes. 1994. Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates. J. Clin. Microbiol. 32:2291-2294.
22. Kasper, P., R. Kaiser, J. P. Klein, J. Oldenburg, H. H. Brackmann, J. Rockstroh, and K. E. Schneweis. 1993. Diversification of HIV-1 strains after infection from a unique source. AIDS Res. Hum. Retroviruses 9:153-157.
23. Kliks, S. C., D. W. Wara, D. V. Landers, and J. A. Levy. 1994. Features of HIV-1 that could influence maternal-child transmission. JAMA 272:467-474.
24. Korber, B. T. M., G. Learn, J. Mullins, B. Hahn, and S. Wolinsky. 1995. Protecting the databases. Nature (London) 378:242-243.
25. Lamers, S. L., J. W. Sleasman, J. X. She, K. A. Barrie, S. M. Pomeroy, D. J. Barrett, and M. M. Goodenow. 1993. Independent variations and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo. J. Virol. 67:3951-3960.
26. Lamers, S. L., J. W. Sleasman, J. X. She, K. A. Barrie, S. M. Pomeroy, D. J. Barrett, and M. M. Goodenow. 1994. Persistence of multiple maternal genotypes of human immunodeficiency virus type 1 in infants infected by vertical transmission. J. Clin. Invest. 93:380-390.
27. Liu, Z.-Q., C. Wood, J. A. Levy, and C. Cheng-Mayer. 1990. The viral envelope gene is involved in the macrophage tropism of a human immuno-deficiency virus type I strain isolated from brain tissue. J. Virol. 64:6148-6153.
28. McNearney, T., Z. Hornickova, B. Kloster, A. Birdwell, G. A. Storch, S. H. Polmar, M. Arens, and L. Ratner. 1993. Evolution of sequence divergence among human immunodeficiency virus type I isolates derived from a blood donor and a recipient. Pediatr. Res. 33:36-42.
29. McNearney, T., Z. Hornickova, R. Markham, A. Birdwell, M. Arens, A. Saah, and L. Ratner. 1992. Relationship of human immunodeficiency virus type I sequence heterogeneity to stage of disease. Proc. Natl. Acad. Sci. USA 89:10247-10251.
30. Mulder-Kampinga, G. A., C. Kuiken, J. Dekker, H. J. Scherpbier, K. Boer, and J. Goudsmit. 1993. Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intra-uterine virus transmission. J. Gen. Virol. 74:1747-1756.
31. Myers, G., A. B. Rabson, S. F. Josephs, T. F. Smith, J. A. Berzofsky, and F. Wong-Slaal (ed.). 1994. Human retroviruses and AIDS. Los Alamos National Laboratory. Los Alamos, N.M.
32. O'Brian, W. A., A. Koyanagi, A. Namazie, J. Q. Zhao, A. Diagne, K. Idler, J. A. Zack, and I. S. Y. Chen. 1990. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature (London) 348:167-169.
33. Pollack, H., M. X. Zhan, T. Ilmet-Moore, K. Ajuang-Simbiri, K. Krasinski, and W. Borkowsky. 1993. Ontogeny of anti-human immunodeficiency virus (HIV) antibody production in HIV-1 infected infants. Proc. Natl. Acad. Sci. USA 90:2340-2344.
34. Rogers, M. F., C.-Y. Ou, M. Rayfield, P. A. Thomas, E. E. Schoenbaum, E. Abrams, K. Krasinski, P. A. Selwyn, J. Moore, A. Kaul, K. T. Grimm, M. Bamji, S. Schochetman, and the New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. 1989. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. N. Engl. J. Med. 320:1649-1654.
35. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
36. Scarlatti, G., J. Albert, P. Rossi, V. Hodara, P. Biraghi, L. Muggiasca, and E. M. Fenyo. 1993. Mother-to-child transmission of human immunodeficiency virus type I: correlation with neutralizing antibodies against primary isolates. J. Infect. Dis. 168:207-210.
37. Shioda, T., J. A. Levy, and C. Cheng-Mayer. 1991. Macrophages and T-cell line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature (London) 349:167-169.
38. Spencer, L. T., M. T. Ogino, W. M. Dankner, and S. A. Spector. 1994. Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children. J. Infect. Dis. 169:491-495.
39. Tersmette, M., J. M. A. Lange, R. E. Y. deGoede, F. de Wolf, J. K. M. Edfind Schattenkerk, P. T. A. Schellekens, R. A. Coutinho, H. G. Huisman, J. Goudsmit, and F. Meidema. 1989. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1:983-985.
40. Tovo, P. A., M. De Martino, C. Gabiano, N. Cappelo, R. D'Elia, A. Loy, A. Plebani, G. V. Zuccotti, P. Dallacasa, G. Ferraris, D. Caselli, C. Fundaro, P. D'Argenio, L. Galli, N. Principi, M. Stegagno, E. Ruga, E. Palomba, and the Italian Register for HIV Infection in Children. 1992. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 339:1249-1253.
41. Westervelt, P., D. B. Trowbridge, L. G. Epstein, B. M. Blumberg, Y. Li, B. H. Hahn, G. M. Shaw, R. W. Price, and L. Ratner. 1992. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J. Virol. 66:2577-2582.
42. Wolinsky, S. M., C. M. Wike, B. T. M. Korber, C. Hutto, W. P. Parks, L. L. Rosenblum, K. J. Kuntsman, M. R. Furtado, and J. L. Munoz. 1992. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255:1134-1137.
43. Zack, J. A., A. M. Haislip, P. Krogstad, and I. S. Chen. 1992. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66:1717-1725.